Utilization of bevacizumab in US elderly patients with colorectal cancer receiving chemotherapy

OBJECTIVE: Bevacizumab, the first FDA-approved anti-angiogenesis agent, has been used for metastatic colorectal cancer since 2004. This study evaluated the utilization of bevacizumab among elderly metastatic colorectal cancer patients in the United States. METHODS: Using Surveillance and Epidemiolog...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:J Oncol Pharm Pract
Päätekijät: Fu, Alex Z, Tsai, Huei-Ting, Marshall, John L, Freedman, Andrew N, Potosky, Arnold L
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: 2013
Aiheet:
Article
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC4883010/
https://ncbi.nlm.nih.gov/pubmed/24122849
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1078155213507010
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia